{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:41:15Z","timestamp":1791942075045,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bone.2014.12.003","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T14:33:44Z","timestamp":1418308424000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"special_numbering":"C","title":["Secular trends in the incidence of primary hyperparathyroidism over five decades (1965\u20132010)"],"prefix":"10.1016","volume":"73","author":[{"given":"Marcio L.","family":"Griebeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euijung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Hathcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"L. Joseph","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wermers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.bone.2014.12.003_bb0005","first-page":"N12","article-title":"The epidemiology of primary hyperparathyroidism in North America","volume":"17","author":"Melton","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.12.003_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2014.12.003_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.12.003_bb0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","article-title":"Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK","volume":"71","author":"Yu","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.bone.2014.12.003_bb0025","first-page":"A4567","article-title":"Increasing incidence of primary hyperparathyroidism in Denmark","volume":"60","author":"Abood","year":"2013","journal-title":"Dallas Med J"},{"key":"10.1016\/j.bone.2014.12.003_bb0030","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0895-4356(00)00239-0","article-title":"Primary hyperparathyroidism detected in a health screening. The Tromso study.","volume":"53","author":"Jorde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bone.2014.12.003_bb0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965\u20131992","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bone.2014.12.003_bb0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.12.003_bb0045","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.12.003_bb0050","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.bone.2014.12.003_bb0055","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bone.2014.12.003_bb0060","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwq482","article-title":"Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project","volume":"173","author":"St Sauver","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bone.2014.12.003_bb0065","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.164.14.1525","article-title":"National trends in osteoporosis visits and osteoporosis treatment, 1988\u20132003","volume":"164","author":"Stafford","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bone.2014.12.003_bb0070","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","article-title":"Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women","volume":"87","author":"Tannenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.12.003_bb0075","series-title":"Physician's guide to prevention and treatment of osteoporosis","first-page":"1","author":"National Osteoporosis Foundation","year":"1998"},{"key":"10.1016\/j.bone.2014.12.003_bb0080","first-page":"1139","article-title":"Patterns of use of the bone mineral density test in Ontario, 1992\u20131998","volume":"163","author":"Jaglal","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.bone.2014.12.003_bb0085","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2146\/ajhp080248","article-title":"Trends and determinants of prescription medication use for treatment of osteoporosis","volume":"66","author":"Farley","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bone.2014.12.003_bb0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-100-5-633","article-title":"Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism","volume":"100","author":"Marcus","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bone.2014.12.003_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2014.12.003_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-140-3-200402030-00009","article-title":"Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results","volume":"140","author":"Haas","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bone.2014.12.003_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2014.12.003_bb0110","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","article-title":"Association between primary hyperparathyroidism and increased body weight: a meta-analysis","volume":"90","author":"Bolland","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.12.003_bb0115","first-page":"715","article-title":"Calcium infusion suggests a \u201cset-point\u201d abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism","volume":"76","author":"Khosla","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.12.003_bb0120","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJM198510313131805","article-title":"Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism","volume":"313","author":"Insogna","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.12.003_bb0125","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/jcem-70-4-951","article-title":"Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism","volume":"70","author":"Tohme","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.12.003_bb0130","first-page":"1054","article-title":"Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications","volume":"85","author":"Rao","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.12.003_bb0135","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2014.12.003_bb0140","doi-asserted-by":"crossref","first-page":"e6390","DOI":"10.1136\/bmj.e6390","article-title":"Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study","volume":"345","author":"Paik","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2014.12.003_bb0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jada.2011.02.014","article-title":"Calcium intake in the United States from dietary and supplemental sources across adult age groups: new estimates from the National Health and Nutrition Examination Survey 2003\u20132006","volume":"111","author":"Mangano","year":"2011","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.bone.2014.12.003_bb0150","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3945\/jn.109.118539","article-title":"Estimation of total usual calcium and vitamin D intakes in the United States","volume":"140","author":"Bailey","year":"2010","journal-title":"J Nutr"},{"key":"10.1016\/j.bone.2014.12.003_bb0155","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973\u20132002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2014.12.003_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/eje.0.1500133","article-title":"Advances in diagnostic practices affect thyroid cancer incidence in France","volume":"150","author":"Leenhardt","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2014.12.003_bb0165","first-page":"N2","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"17","author":"Bilezikian","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.12.003_bb0170","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/jwh.2012.3517","article-title":"Effect of reimbursement reductions on bone mineral density testing for female Medicare beneficiaries","volume":"21","author":"Yoo","year":"2012","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214004554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214004554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T22:51:22Z","timestamp":1538002282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214004554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"alternative-id":["S8756328214004554"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.12.003","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965\u20132010)","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}